Serum levels of adiponectin in patients with aseptic loosening after total hip replacement

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 2, 2010, Pages 748-752

  Landgraeber, Stefan ^a   Wegner, Alexander ^a   Canbay, Ali ^a   Von Knoch, Marius ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adiponectin; Apoptosis; Aseptic loosening; Osteolysis; Wear debris

Indexed keywords

ADIPONECTIN; APOPTOSIS; ASEPTIC LOOSENING; OSTEOLYSIS; WEAR DEBRIS;

CELL DEATH; DEBRIS; GLUCOSE; HIP PROSTHESES;

BODY FLUIDS;

ADIPONECTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE METABOLISM; HIP ARTHROPLASTY; HUMAN; INFLAMMATION; LIPID METABOLISM; MALE; PROSTHESIS LOOSENING; SURVIVAL RATE; TOTAL HIP PROSTHESIS;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTORS; ROC CURVE;

EID: 77950219252     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32583     Document Type: Article

References (31)

1. Silva MJ, Sandell LJ. What's new in orthopaedic research. J Bone Joint Surg Am 2002;84-A:1490-1496.
2. Landgraeber S, Toetsch M, Wedemeyer C, Saxler G, Tsokos M, von Knoch F, Neuhauser M, Loer F, von Knoch M. Overexpression of p53/BAK in aseptic loosening after total hip replacement. Biomaterials 2006;27:3010-3020.
3. Landgraeber S, von Knoch M, Loer F, Wegner A, Tsokos M, Hussmann B, Totsch M. Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement. Biomaterials 2008;29:3444-3450.
4. Landgraeber S, Jaeckel S, Loer F, Wedemeyer C, Hilken G, Canbay A, Totsch M, von Knoch M. Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis. Apoptosis 2009;14:173-181.
5. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002;2:965-975.
6. Canbay A, Friedman S, Gores GJ. Apoptosis: The nexus of liver injury and fibrosis. Hepatology 2004;39:273-278.
7. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S, Walsh K. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 2007;117:375-386.
8. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-566.
9. Tataranni PA, Ortega E. A burning question: Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on Type 2 diabetes? Diabetes 2005;54:917-927.
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in Type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
11. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1-12.
12. Wedemeyer I, Bechmann LP, Odenthal M, Jochum C, Marquitan G, Drebber U, Gerken G, Gieseler RK, Dienes HP, Canbay A. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C. J Hepatol 2009;50:140-149.
13. Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-1999. J Bone Joint Surg Br 2001;83:579-586.
14. Keener JD, Callaghan JJ, Goetz DD, Pederson DR, Sullivan PM, Johnston RC. Twenty-five-year results after Charnley total hip arthroplasty in patients less than fifty years old: A concise follow-up of a previous report. J Bone Joint Surg Am 2003;85A:1066-1072.
15. Skeie S, Lende S, Sjoberg EJ, Vollset SE. Survival of the Charnley hip in coxarthrosis. A 10-15-year follow-up of 629 cases. Acta Orthop Scand 1991;62:98-101.
16. Harris WH, McGann WA. Loosening of the femoral component after use of the medullary-plug cementing technique. Follow-up note with a minimum five-year follow-up. J Bone Joint Surg Am 1986;68:1064-1066.
17. Hodgkinson JP, Shelley P, Wroblewski BM. The correlation between the roentgenographic appearance and operative findings at the bone-cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop Relat Res 1988:105-109.
18. McAuley JP, Moore KD, Culpepper WJ II, Engh CA. Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am 1998;80:1648-1655.
19. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, Guariento S, Bosello O, Zamboni M. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci 2004;59:M935-M939.
20. Maiolino G, Cesari M, Sticchi D, Zanchetta M, Pedon L, Antezza K, Pessina AC, Rossi GP. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 2008;93:3333-3340.
21. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H, Sugiura K, Kondo T, Murohara T, Toyoshima H. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 2006;188:184-189.
22. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002;106:2767-2770.
23. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472-480.
24. Wang JT. The role of particulate orthopaedic implant materials in peri-implant osteolysis. In: Morrey BF, editor. Biological, Material, and Mechanical Considerations of Joint Replacement. New York: Raven Press Ltd.; 1993. p 122.
25. Savill J, Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 1995;6:385-393.
26. Wang L, Antonini JM, Rojanasakul Y, Castranova V, Scabilloni JF, Mercer RR. Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis. J Cell Physiol 2003;194:215-224.
27. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003;112:152-159.
28. Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman symposium. Hepatology 2006;43:872-878.
29. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
30. Yokoyama H, Hirose H, Ohgo H, Saito I. Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 2004;43:453-457.
31. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, van Baar ME, Verhaar JA, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: A systematic review. Rheumatology (Oxford) 2002;41:1155-1162.